Spots Global Cancer Trial Database for prostate
Every month we try and update this database with for prostate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer | NCT00853697 | Prostate Cancer Castration-resi... | testosterone (A... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Prostate Cancer Intervention Versus Observation Trial (PIVOT) | NCT00007644 | Prostate Cancer | Radical prostat... | - 75 Years | VA Office of Research and Development | |
| MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer Detection | NCT03819751 | Prostate Cancer Prostate Neopla... | MRI-targeted pr... | 50 Years - 75 Years | Universitaire Ziekenhuizen KU Leuven | |
| An Alternative to A Fixed Schedule In Management Of Prostate Cancer | NCT01056562 | Prostate Cancer | - | University Health Network, Toronto | ||
| A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours | NCT05605522 | Pancreatic Duct... Squamous Cell C... Colorectal Canc... Gastric Cancer Ewing Sarcoma NTSR1 Expressin... Neuroendocrine ... | [225]-FPI-2059 [111In]-FPI-205... | 18 Years - | Fusion Pharmaceuticals Inc. | |
| Radioimmunotherapy in Prostate Cancer Using 177Lu-J591 Antibody | NCT00538668 | Prostate Cancer | 117Lu-J591 | 21 Years - 85 Years | Weill Medical College of Cornell University | |
| Pilot Study to Assess the Safety and Efficacy of BioProtect Balloon in Prostate Cancer Subjects | NCT00918229 | Prostate Cancer | balloon implant Balloon implant... | 45 Years - 85 Years | BioProtect | |
| Application of Megavoltage Imaging to Reduce Artifact After Seed Implants | NCT01810627 | Prostate Cancer | MVCT | 50 Years - 80 Years | University of Kentucky | |
| Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer | NCT04428203 | Prostate Cancer... Prostate Cancer Prostate Adenoc... | Epidiolex Oral ... | 18 Years - | University of Kentucky | |
| Rectal Gas Removal Through Small Catheter Placement Prior to MRI of the Prostate | NCT03987737 | Prostatic Neopl... Prostate Cancer | small urinary c... | 45 Years - 80 Years | Universitaire Ziekenhuizen KU Leuven | |
| Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel | NCT00082134 | Hormone-refract... | ILX651 | 19 Years - | Sanofi | |
| A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC) | NCT01090765 | Prostate Cancer Metastatic Cast... | TRC105 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| INTERVAL - Intense Exercise Trial for Men With Metastatic Castrate-Resistant Prostate Cancer | NCT04507698 | Prostate Cancer | Intensive Exerc... | 18 Years - | Guy's and St Thomas' NHS Foundation Trust | |
| A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors | NCT02605083 | Cancer | eFT508 | 18 Years - | Effector Therapeutics | |
| Intensity Modulated Radiation Therapy for Prostate Cancer | NCT00214422 | Prostate Cancer | Radiation | 18 Years - 90 Years | National Institutes of Health Clinical Center (CC) | |
| PRO-STATE:Search for a Protein Profile Corresponding to Fast-developing Lesions and Characterization of Implicated Proteins in Prostate Carcinoma | NCT00427817 | Adenoma, Prosta... | 18 Years - | University Hospital, Grenoble | ||
| A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies | NCT04503265 | Advanced Malign... Breast Cancer Ovarian Cancer Homologous Reco... Prostate Cancer Pancreatic Canc... | AMXI-5001:Dose ... AMXI-5001:Dose ... | 18 Years - | AtlasMedx, Incorporated | |
| Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer | NCT00941915 | Prostate Cancer | SBRT Prostate | 40 Years - 82 Years | Duke University | |
| Trans-rectal Focal Microwave Ablation of the Index Tumor in Patients With Low-risk Prostate Cancer | NCT03023345 | Low-Risk Prosta... | Microwave trans... | 45 Years - 76 Years | Assistance Publique - Hôpitaux de Paris | |
| BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes | NCT03432897 | Prostate Cancer Adenocarcinoma ... | Olaparib Pill Prostatectomy | 18 Years - | Brown University | |
| Unilateral Nerve-Sparing Cryoablation for Low-Risk, Clinically Localized, Unilateral Prostate Cancer | NCT02459912 | Prostate Cancer | Unilateral Nerv... Precise Cryoabl... | 40 Years - 69 Years | NYU Langone Health | |
| TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer | NCT04887506 | Metastatic Cast... Metastatic Cast... Metastatic Pros... | TAVT-45 Zytiga Prednisone | 18 Years - | Tavanta Therapeutics | |
| Improving Erectile Function and Quality of Life After Prostate Cancer Treatment | NCT01996852 | Prostate Cancer Erectile Dysfun... Erectile Dysfun... Erectile Dysfun... | Cognitive-behav... sildenafil citr... Vacuum Constric... | 21 Years - | Case Comprehensive Cancer Center | |
| Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer | NCT00323882 | Prostate Cancer Neoplasm Metast... | MDX-010 | 18 Years - | Bristol-Myers Squibb | |
| Prostate Biomarker Study | NCT00574899 | Prostate Cancer | Questioners, bl... Questioners, bl... | 35 Years - | Memorial Sloan Kettering Cancer Center | |
| Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer | NCT00582140 | Prostate Cancer | pTVG-HP with rh... pTVG-HP with rh... pTVG-HP with rh... | 18 Years - | University of Wisconsin, Madison | |
| Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer | NCT01492972 | Prostate Cancer | Radiation Androgen Suppre... | 18 Years - | Proton Collaborative Group | |
| Prostatic Artery Embolization in Advanced Prostate Cancer | NCT03457805 | Prostate Cancer Bladder Outlet ... | Prostatic Arter... | - | Cantonal Hospital of St. Gallen | |
| Tenovus Cancer Choirs Study: the Benefits of Singing for Those Affected by Cancer | NCT02756780 | Cancer | Tenovus Cancer ... | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer | NCT02749825 | Prostate Cancer | Trelstar Lupron Zoladex | 18 Years - | Pharmatech | |
| Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer | NCT03963739 | Prostate Adenoc... Stage I Prostat... Stage II Prosta... Stage III Prost... | Interview Questionnaire A... | 18 Years - | Wake Forest University Health Sciences | |
| Ion Prostate Irradiation | NCT01641185 | Prostatic Neopl... | radiation | 40 Years - 80 Years | Heidelberg University | |
| Study Using CP-461 to Treat Advanced Prostate Cancer | NCT00036075 | Prostate Cancer | CP-461 | 18 Years - | Astellas Pharma Inc | |
| Choline PET/CT and MRI for Targeted Prostate Biopsy | NCT01751737 | Prostate Cancer | Prostate Cancer... | 40 Years - | University of Michigan | |
| Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS) | NCT01250483 | Benign Prostati... Prostate Cancer | PSA measurement... | 40 Years - 80 Years | Seoul National University Hospital | |
| Analyzing Clinical Trial Experiences of Prostate Cancer Patients | NCT05411354 | Prostate Cancer | 18 Years - | Power Life Sciences Inc. | ||
| Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC | NCT01062503 | Metastatic Pros... Bone Metastasis | Zoledronic acid | 18 Years - | University Health Network, Toronto | |
| Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer | NCT01543659 | Prostate Cancer | 89Zr-DFO-huJ591 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Pedometer and Exercise Study in Prostate Cancer Patients With Hormonal Therapy | NCT00868868 | Prostate Cancer | 18 Years - | Groupe de recherche en Urologie de la Mauricie | ||
| Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer | NCT02031328 | Prostate Adenoc... | Stereotactic Ab... | 18 Years - | Sunnybrook Health Sciences Centre | |
| Investigating the Effects of AZD2014 Therapy Given Prior to Radical Prostatectomy in Men With High Risk Prostate Cancer | NCT02064608 | Prostate Cancer | AZD2014 | 18 Years - | Cambridge University Hospitals NHS Foundation Trust | |
| Red Yeast Rice in Subjects With Clinically Localized Prostate Cancer Undergoing Active Surveillance | NCT01687049 | Prostate Cancer | Red yeast rice | 19 Years - 90 Years | Sunnybrook Health Sciences Centre | |
| Informed Decision Making Intervention in Screening for Prostate Cancer of Predominantly African American Participants in a Community Outreach Program | NCT02419846 | Prostate Carcin... | Educational Int... digital rectal ... Pre-test admini... Survey Administ... Prostate-specif... Post test admin... | 19 Years - | Case Comprehensive Cancer Center | |
| Focal Prostate Radio-Frequency Ablation | NCT02328807 | Prostate Cancer | Radio-Frequency... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017) | NCT00110188 | Prostate Cancer | ridaforolimus | 18 Years - | Merck Sharp & Dohme LLC | |
| The Effect of Radiation on Semen Quality and Fertility in Men With Prostate Cancer | NCT00496249 | Prostate Cancer | 18 Years - 55 Years | University Health Network, Toronto | ||
| Motorised Probe Holder Assisting Prostate Biopsies | NCT02132975 | Prostate Cancer | Biopsies using ... Biopsies using ... | 18 Years - | University Hospital, Grenoble | |
| Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy | NCT00480857 | Prostate Cancer | Docetaxel (Taxo... | 18 Years - | University of Michigan Rogel Cancer Center | |
| Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer | NCT01393730 | Prostate Cancer | Abiraterone ace... Dutasteride Prednisone | 18 Years - | Dana-Farber Cancer Institute | |
| MagneThermoPro : Magnetic Resonance Thermography of Human Prostate | NCT04822272 | Prostate Cancer... | MRI thermometry | 18 Years - | University Hospital, Bordeaux | |
| Comparison Of DIR-MRI And DCE-MRI In Detection Of Prostate Cancer: A Pilot Study | NCT02939456 | Cancer of the P... | Magnetic Resona... | 18 Years - | University Hospitals of North Midlands NHS Trust | |
| An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ... | NCT00924092 | Prostate Cancer Breast Cancer Lung Cancer Colorectal Canc... Head and Neck C... | GI-6207 [Recomb... (Yeast CEA Vacc... | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer | NCT00570700 | Hormone-refract... Adenocarcinoma ... Hormone-resista... Prostate Cancer Recurrent Prost... | Dasatinib | 18 Years - | University of California, Irvine | |
| A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer | NCT01187485 | Prostate Cancer | Androderm® 2.5m... Androderm® 5.0m... Androderm® 7.5m... | 18 Years - | University of Chicago | |
| Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone | NCT01428219 | Prostate Cancer... | Cabozantinib | 18 Years - | University of Michigan Rogel Cancer Center | |
| Devel. and Eval. of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate Cancer | NCT02342626 | Adenocarcinoma ... | Dashboard | 40 Years - 85 Years | University of Rochester | |
| GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer | NCT00089856 | Prostate Cancer | Immunotherapy w... Chemotherapy (T... | 18 Years - | Cell Genesys | |
| Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI | NCT05220501 | Prostate Cancer | Micro-US Target... MRI Targeted Bi... | 18 Years - | Sunnybrook Health Sciences Centre | |
| A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer | NCT01288911 | Prostatic Neopl... | enzalutamide bicalutamide | 18 Years - | Astellas Pharma Inc | |
| Hypofractionated Radiotherapy Versus Stereotactic Irradiation With Hyaluronic Acid | NCT02361515 | Prostatic Adeno... | Moderate hypofr... Stereotactic ra... | 18 Years - 80 Years | Hospices Civils de Lyon | |
| First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer | NCT05189457 | Prostate Cancer Stage IV Prosta... | Luteinizing Hor... New Hormonal Ag... Docetaxel Tislelizumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Evaluation of Radiation Therapy Positioning System (RTPS) in Patients With Localized Prostate Cancer | NCT00921193 | Prostate Cancer | Radiation Thera... | 45 Years - | Navotek Medical, Ltd. | |
| Lenalidomide and Paclitaxel in Prostate Cancer | NCT00933426 | Prostate Cancer | Lenalidomide Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer | NCT04887506 | Metastatic Cast... Metastatic Cast... Metastatic Pros... | TAVT-45 Zytiga Prednisone | 18 Years - | Tavanta Therapeutics | |
| Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer | NCT00519285 | Prostatic Neopl... Neoplasm Metast... | Aflibercept Placebo (for af... Docetaxel Prednisone or P... | 18 Years - | Sanofi | |
| Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial | NCT02024685 | Adenocarcinoma ... Adenocarcinoma ... Adenocarcinoma ... Adenocarcinoma ... | Personalized Tr... Standard patien... | - | Case Comprehensive Cancer Center | |
| Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy | NCT03725761 | Prostate Cancer | Sacituzumab Gov... | 18 Years - | University of Wisconsin, Madison | |
| Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metastases-related Pain in Patients With Prostate Cancer | NCT00375648 | Pain | Zoledronic acid | 18 Years - | Novartis | |
| A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer | NCT00430235 | Adenocarcinoma ... | BAY 43-9006 | 18 Years - | British Columbia Cancer Agency | |
| I-125 Versus Pd-103 for Low Risk Prostate Cancer | NCT00494039 | Prostate Cancer | Radioactive see... | 40 Years - 80 Years | VA Puget Sound Health Care System | |
| Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma | NCT00132301 | Prostate Cancer | Docetaxel Prednisone | - | VA Office of Research and Development | |
| Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study | NCT06430411 | Prostate Cancer... Prostate Cancer... Prostate Cancer Prostate Neopla... Oligometastatic... Oligometastasis | Radical prostat... Prostate irradi... Surgical metast... Irradiation of ... Abiraterone ace... Enzalutamide Darolutamide Apalutamide Docetaxel Lutetium-PSMA Androgen depriv... | 18 Years - 80 Years | Medical University of Vienna | |
| Conventional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer Patients | NCT01401972 | Prostate Cancer | - | Sunnybrook Health Sciences Centre | ||
| Heuristics, Algorithms and Machine Learning: Evaluation & Testing in Radiation Therapy | NCT04060706 | Cancer | Radical Image-G... | 18 Years - | Cambridge University Hospitals NHS Foundation Trust | |
| Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer | NCT01617174 | Prostate Cancer | Webcore telepho... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| The SPARC Trial: Stereotactic Prostate Ablative Radiotherapy Using Cyberknife | NCT02145494 | Prostate Cancer | Radiotherapy | - | Royal Marsden NHS Foundation Trust | |
| TNFerade Biologic to Treat Locally Advanced Prostate Cancer | NCT01048151 | Locally Advance... | TNFerade™ Biolo... | - | GenVec | |
| MagneThermoPro : Magnetic Resonance Thermography of Human Prostate | NCT04822272 | Prostate Cancer... | MRI thermometry | 18 Years - | University Hospital, Bordeaux | |
| Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer | NCT02749825 | Prostate Cancer | Trelstar Lupron Zoladex | 18 Years - | Pharmatech | |
| DEPORRA-CoProst: Assessment of New Fluorescence Imagery Techniques Using Prostate Chips From Transurethral Resections | NCT02185170 | Prostate Cancer | Trans-urethral ... Use of the FEMT... Use of the Ligh... | 18 Years - | University Hospital, Grenoble |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
